Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1974 Mar 23;1(5907):547–548. doi: 10.1136/bmj.1.5907.547

Survival and the HL-A System in Acute Lymphoblastic Leukaemia

Sylvia D Lawler, P T Klouda, P G Smith, Morwenna M Till, R M Hardisty
PMCID: PMC1633664  PMID: 4522239

Abstract

The relation between the HL-A antigens and survival has been studied in 58 patients with acute lymphoblastic leukaemia. Patients with the HL-A9 antigen had the best estimated median survival times, the highest ratio of survivors to non-survivors, and the lowest median age at diagnosis. The data suggest that resistance to acute lymphoblastic leukaemia may be associated with the HL-A9 antigen.

Full text

PDF
548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lawler S. D., Klouda P. T., Hardisty R. M., Till M. M. The HL-A system in lymphoblastic leukaemia. A study of patients and their families. Br J Haematol. 1971 Nov;21(5):595–605. doi: 10.1111/j.1365-2141.1971.tb02720.x. [DOI] [PubMed] [Google Scholar]
  2. Rogentine G. N., Jr, Yankee R. A., Gart J. J., Nam J., Trapani R. J. HL-A antigens and disease. Acute lymphocytic leukemia. J Clin Invest. 1972 Sep;51(9):2420–2428. doi: 10.1172/JCI107055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Walford R. L., Smith G. S., Waters H. Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev. 1971;7:78–111. doi: 10.1111/j.1600-065x.1971.tb00464.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES